Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones
CAMBRIDGE, Mass., October 23, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the“Company”), a wearable medical robotics company that offers increased functionality for those
suffering from neurological disorders and upper limb paralysis, today announced that it has entered into a term loan agreement with Chicago Venture Partners (CVP) for $3 million. Myomo expects to use the proceeds to continue to grow the company’s pipeline of qualified MyoPro candidates, introduce the new pediatric version of its MyoPro orthosis, and for general corporate purposes. Read more.